Hadasit Bio Working Capital vs. Market Capitalization
| HDST Stock | 53.10 0.00 0.00% |
For Hadasit Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hadasit Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hadasit Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hadasit Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hadasit Bio over time as well as its relative position and ranking within its peers.
Hadasit |
Hadasit Bio Market Capitalization vs. Working Capital Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hadasit Bio's current stock value. Our valuation model uses many indicators to compare Hadasit Bio value to that of its competitors to determine the firm's financial worth. Hadasit Bio is one of the top stocks in working capital category among related companies. It is one of the top stocks in market capitalization category among related companies creating about 0.29 of Market Capitalization per Working Capital. The ratio of Working Capital to Market Capitalization for Hadasit Bio is roughly 3.49 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hadasit Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hadasit Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hadasit Bio's earnings, one of the primary drivers of an investment's value.Hadasit Market Capitalization vs. Working Capital
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Hadasit Bio |
| = | 59 M |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Hadasit Bio |
| = | 16.9 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Hadasit Market Capitalization vs Competition
Hadasit Bio is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 491.4 Million. Hadasit Bio holds roughly 16.9 Million in market capitalization claiming about 3% of equities under Health Care industry.
Hadasit Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hadasit Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hadasit Bio will eventually generate negative long term returns. The profitability progress is the general direction of Hadasit Bio's change in net profit over the period of time. It can combine multiple indicators of Hadasit Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel.
Hadasit Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hadasit Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hadasit Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hadasit Bio's important profitability drivers and their relationship over time.
Use Hadasit Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hadasit Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hadasit Bio will appreciate offsetting losses from the drop in the long position's value.Hadasit Bio Pair Trading
Hadasit Bio Pair Trading Analysis
The ability to find closely correlated positions to Hadasit Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hadasit Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hadasit Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hadasit Bio to buy it.
The correlation of Hadasit Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hadasit Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hadasit Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hadasit Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hadasit Bio position
In addition to having Hadasit Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
To fully project Hadasit Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hadasit Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hadasit Bio's income statement, its balance sheet, and the statement of cash flows.